1. Young KC, Shi GY, Chang YF, Chang BI, Chang LC, Lai MD, Chuang WJ, Wu HL: Interaction of streptokinase and plasminogen. Studied with truncated streptokinase peptides. J Biol Chem. 1995, 270: 29601-29606. 10.1074/jbc.270.49.29601.
2. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI): Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet. 1986, 1: 397-402.
3. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group: Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988, 2: 349-360.
4. Toruncha A, Torres W, Mora E, León L, Padrón N, Castañeda M, Martínez M, Pardo A, Zamora R, Galhardo M, Pérez A, Banasco J, Jiménez R, Fariñas H, Mainet D, Sorell L, Estrada MP, de la Fuente J: Comparative clinical trial in patients with acute myocardial infarction using recombinant and natural streptokinase. Biotecnología Aplicada. 1992, 9: 289-291.
5. Llerena L, Llerena R, Rodríguez-de la Vega A, Valdés-Rucabado JA, Fernández-Felipe R, Rodríguez-Bereau C: Trombolisis intracoronaria con Estreptoquinasa Recombinante (SK-R) en el infarto agudo del miocardio. XVII Congreso Nacional de Cardiología, Guadalajara, Jalisco (México). Septiembre 29–Octubre 3, 1991